CUBE vs TERN
CubeSmart (CUBE) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CUBE and TERN stock pages for the full models.
Not investment advice.